WO2008102855A1 - 軟骨疾患治療用組成物 - Google Patents
軟骨疾患治療用組成物 Download PDFInfo
- Publication number
- WO2008102855A1 WO2008102855A1 PCT/JP2008/052999 JP2008052999W WO2008102855A1 WO 2008102855 A1 WO2008102855 A1 WO 2008102855A1 JP 2008052999 W JP2008052999 W JP 2008052999W WO 2008102855 A1 WO2008102855 A1 WO 2008102855A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cartilage
- composition
- effect
- treatment
- inflammation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/734—Alginic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
- A61L27/3834—Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
- A61L27/3843—Connective tissue
- A61L27/3852—Cartilage, e.g. meniscus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/06—Materials or treatment for tissue regeneration for cartilage reconstruction, e.g. meniscus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cell Biology (AREA)
- Dermatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Developmental Biology & Embryology (AREA)
- Botany (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Virology (AREA)
- Biotechnology (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
Abstract
Priority Applications (26)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0807739-8A BRPI0807739B1 (pt) | 2007-02-21 | 2008-02-21 | Composição para o tratamento de doenças da cartilagem |
CN200880004925.6A CN101951969B (zh) | 2007-02-21 | 2008-02-21 | 用于治疗软骨疾病的组合物 |
KR1020097016862A KR101440170B1 (ko) | 2007-02-21 | 2008-02-21 | 연골 질환 치료용 조성물 |
ES08720791.6T ES2637163T3 (es) | 2007-02-21 | 2008-02-21 | Composición de tratamiento de condropatías |
EP17157935.2A EP3189859B8 (en) | 2007-02-21 | 2008-02-21 | Composition for treatment of cartilage disease |
CA2677436A CA2677436C (en) | 2007-02-21 | 2008-02-21 | Composition for treatment of cartilage disease |
MX2009008760A MX2009008760A (es) | 2007-02-21 | 2008-02-21 | Composicion para el tratamiento de enfermedades del cartilago. |
NZ578985A NZ578985A (en) | 2007-02-21 | 2008-02-21 | Composition for treatmet of cartilage disease comprising a monovalent metal salt of alginic acid |
AU2008217916A AU2008217916B2 (en) | 2007-02-21 | 2008-02-21 | Composition for treatment of cartilage disease |
US12/311,426 US8372394B2 (en) | 2007-02-21 | 2008-02-21 | Compositions and methods for treating cartilage disease |
JP2009500239A JP4740369B2 (ja) | 2007-02-21 | 2008-02-21 | 軟骨疾患治療用組成物 |
EP08720791.6A EP2127687B1 (en) | 2007-02-21 | 2008-02-21 | Composition for treatment of cartilage disease |
ES08792674T ES2427730T3 (es) | 2007-10-24 | 2008-08-19 | Composición para el tratamiento de la artritis reumatoide |
CA2703158A CA2703158C (en) | 2007-10-24 | 2008-08-19 | Composition for treatment of joint disease |
JP2009537986A JP5491866B2 (ja) | 2007-10-24 | 2008-08-19 | 関節疾患治療用組成物 |
PCT/JP2008/065065 WO2009054181A1 (ja) | 2007-10-24 | 2008-08-19 | 関節疾患治療用組成物 |
MX2010004484A MX2010004484A (es) | 2007-10-24 | 2008-08-19 | Composicion para tratamiento de enfermedad de las articulaciones. |
EP08792674.7A EP2210621B1 (en) | 2007-10-24 | 2008-08-19 | Composition for the treatment of rheumatoid arthritis |
BRPI0818719A BRPI0818719B1 (pt) | 2007-10-24 | 2008-08-19 | composição para o tratamento de doença articular |
AU2008315175A AU2008315175B2 (en) | 2007-10-24 | 2008-08-19 | Composition for treatment of joint disease |
NZ584869A NZ584869A (en) | 2007-10-24 | 2008-08-19 | Composition for treatment of joint disease |
KR1020107011185A KR101510494B1 (ko) | 2007-10-24 | 2008-08-19 | 관절 질환 치료용 조성물 |
CN2008801128819A CN101835501B (zh) | 2007-10-24 | 2008-08-19 | 关节疾病治疗用组合物 |
IL200342A IL200342A (en) | 2007-02-21 | 2009-08-11 | A drug used to treat cartilage disease |
US13/737,171 US9216201B2 (en) | 2007-02-21 | 2013-01-09 | Method for regenerating hyaline cartilage |
IL230335A IL230335A (en) | 2007-02-21 | 2014-01-06 | A drug used to treat cartilage disease |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007041520 | 2007-02-21 | ||
JP2007-041520 | 2007-02-21 | ||
JP2007277005 | 2007-10-24 | ||
JP2007-277005 | 2007-10-24 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/311,426 A-371-Of-International US8372394B2 (en) | 2007-02-21 | 2008-02-21 | Compositions and methods for treating cartilage disease |
US13/737,171 Division US9216201B2 (en) | 2007-02-21 | 2013-01-09 | Method for regenerating hyaline cartilage |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2008102855A1 true WO2008102855A1 (ja) | 2008-08-28 |
Family
ID=39710126
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2008/052999 WO2008102855A1 (ja) | 2007-02-21 | 2008-02-21 | 軟骨疾患治療用組成物 |
Country Status (13)
Country | Link |
---|---|
US (2) | US8372394B2 (ja) |
EP (2) | EP3189859B8 (ja) |
JP (2) | JP4740369B2 (ja) |
KR (1) | KR101440170B1 (ja) |
CN (2) | CN101951969B (ja) |
AU (1) | AU2008217916B2 (ja) |
BR (1) | BRPI0807739B1 (ja) |
CA (2) | CA2912930C (ja) |
ES (1) | ES2637163T3 (ja) |
IL (2) | IL200342A (ja) |
MX (1) | MX2009008760A (ja) |
NZ (2) | NZ578985A (ja) |
WO (1) | WO2008102855A1 (ja) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012512846A (ja) * | 2008-12-19 | 2012-06-07 | セリェリクス、ソシエダッド、アノニマ | 脂肪幹細胞を含んでなる組成物 |
WO2013027854A1 (ja) * | 2011-08-23 | 2013-02-28 | 持田製薬株式会社 | 軟骨再生用組成物 |
WO2017043485A1 (ja) | 2015-09-07 | 2017-03-16 | 持田製薬株式会社 | アルギン酸凍結乾燥製剤 |
WO2017163603A1 (ja) | 2016-03-23 | 2017-09-28 | 国立大学法人北海道大学 | 椎間板治療用組成物 |
WO2018159768A1 (ja) | 2017-03-02 | 2018-09-07 | 持田製薬株式会社 | 線維軟骨組織損傷治療用組成物 |
WO2018164128A1 (ja) | 2017-03-07 | 2018-09-13 | 持田製薬株式会社 | アルギン酸液剤 |
WO2019182015A1 (ja) | 2018-03-22 | 2019-09-26 | 持田製薬株式会社 | 非ステロイド性抗炎症性化合物結合アルギン酸誘導体 |
WO2021145404A1 (ja) * | 2020-01-17 | 2021-07-22 | 持田製薬株式会社 | 骨髄液を用いた軟骨損傷治療材 |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101440170B1 (ko) * | 2007-02-21 | 2014-09-12 | 모찌다 세이야쿠 가부시끼가이샤 | 연골 질환 치료용 조성물 |
WO2011031642A2 (en) * | 2009-09-08 | 2011-03-17 | Musculoskeletal Transplant Foundation Inc. | Tissue engineered meniscus repair composition |
US20110059178A1 (en) * | 2009-09-08 | 2011-03-10 | Musculoskeletal Transplant Foundation Inc. | Tissue Engineered Meniscus Repair Composition |
WO2012085609A1 (en) * | 2010-12-20 | 2012-06-28 | Dept. Of Pathobiology | Treatment of osteoarthritis by continuous intra-articular injection of alginate gel |
US10016527B2 (en) | 2012-10-23 | 2018-07-10 | Orthovita, Inc. | Materials and methods for repair of cartilage defects |
US9616093B2 (en) * | 2013-01-30 | 2017-04-11 | NuTech Medical, Inc. | Placental membrane preparation and methods of making and using same |
US10563108B2 (en) * | 2014-04-24 | 2020-02-18 | National University Corporation Hokkaido University | Latent heat storage body, method for producing latent heat storage body and heat exchange material |
JP2017518315A (ja) * | 2014-06-06 | 2017-07-06 | ヴィヴォスクリプト,インコーポレイテッド | 軟骨損傷を修復する方法 |
GB201412236D0 (en) * | 2014-07-09 | 2014-08-20 | Univ Nottingham | Method of producing and using alginate hydrogels |
US10479977B2 (en) * | 2014-11-07 | 2019-11-19 | The Trustees Of Columbia University In The City Of New York | Osteochondroreticular stem cells for bone and cartilage regeneration |
CN106344595B (zh) * | 2015-07-17 | 2020-06-19 | 上海绿谷制药有限公司 | 褐藻胶寡糖及其衍生物在制备治疗疼痛药物中的应用 |
WO2018042405A1 (en) * | 2016-09-05 | 2018-03-08 | A4Tec - Association For The Advancement Of Tissue Engineering And Cell Based Technologies & Therapies A4Tec | Kefiran for use in regenerative medicine and/or tissue engineering |
US11406612B2 (en) | 2018-02-26 | 2022-08-09 | Rensselaer Polytechnic Institute | Method of treatment via intra-articular application of potassium |
JPWO2020045162A1 (ja) * | 2018-08-30 | 2021-08-12 | 学校法人慶應義塾 | 薬物送達用担体 |
WO2021020950A1 (ko) * | 2019-08-01 | 2021-02-04 | 하유진 | 히알루론산과 플루로닉을 포함하는 관절 및 연골 손상 예방 또는 치료용 조성물 |
AU2021206966A1 (en) | 2020-01-14 | 2022-08-04 | Mochida Pharmaceutical Co., Ltd. | Combination and method for treating subject using alginic acid salt |
KR102587871B1 (ko) * | 2020-06-19 | 2023-10-12 | 숙명여자대학교산학협력단 | Bmpr2 유전자 기능획득 돌연변이체를 포함하는 돌연변이 복합체 및 이의 용도 |
Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0513136A (ja) | 1991-06-28 | 1993-01-22 | Nec Corp | Icソケツト |
JPH08269102A (ja) | 1995-03-30 | 1996-10-15 | Shiseido Co Ltd | エンドトキシンフリーのβ1,3−グルカン及びその製造法並びに医療用ゲル素材 |
US5589591A (en) | 1986-07-03 | 1996-12-31 | Advanced Magnetics, Inc. | Endotoxin-free polysaccharides |
JPH09324001A (ja) | 1996-04-02 | 1997-12-16 | Kyowa Hakko Kogyo Co Ltd | ヒアルロン酸ナトリウムの精製法 |
JPH10101577A (ja) * | 1996-09-27 | 1998-04-21 | Nikken Chem Co Ltd | 関節可動域低下症の予防・治療薬 |
WO2002055073A1 (fr) * | 2001-01-05 | 2002-07-18 | Kyowa Kakko Kogyo Co., Ltd. | Agents prophylactiques de l'arthrite |
JP2002530440A (ja) | 1998-11-13 | 2002-09-17 | シーピー ケルコ ユー.エス.インク. | エンドトキシンレベルが低い生体高分子塩、その生体高分子組成物およびこれを製造する方法 |
WO2003099339A1 (fr) * | 2002-05-29 | 2003-12-04 | Anges Mg, Inc. | Composition leurre pour traiter et prevenir une affection inflammatoire |
JP2005036036A (ja) | 2003-07-16 | 2005-02-10 | Tanabe Seiyaku Co Ltd | エンドトキシン除去方法 |
WO2006044342A2 (en) | 2004-10-12 | 2006-04-27 | Fmc Biopolymer As | Self-gelling alginate systems and uses thereof |
JP2007041520A (ja) | 2005-07-29 | 2007-02-15 | Optimax Technology Corp | 光学補償膜の製造方法及び光学補償膜を具有する偏光板 |
JP2007075425A (ja) * | 2005-09-15 | 2007-03-29 | Mochida Pharmaceut Co Ltd | アルギン酸を含む創傷被覆材 |
JP2007277005A (ja) | 2006-03-17 | 2007-10-25 | Kyocera Mita Corp | 画像形成装置 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1985000332A1 (en) * | 1983-07-11 | 1985-01-31 | Donald Earl Burg | Flexible bow seal air ride boat hull |
AU3065192A (en) | 1991-12-20 | 1993-07-28 | Howmedica Inc. | Ultra-pure polysaccharide materials for medical use |
US5266326A (en) | 1992-06-30 | 1993-11-30 | Pfizer Hospital Products Group, Inc. | In situ modification of alginate |
AU742316B2 (en) | 1996-12-10 | 2001-12-20 | Curis, Inc. | Improved hydrogel for tissue engineering |
WO1999015211A1 (en) | 1997-09-19 | 1999-04-01 | Reprogenesis, Inc. | Improved hydrogel for tissue engineering |
TW200307011A (en) * | 2002-04-18 | 2003-12-01 | Chugai Pharmaceutical Co Ltd | Hyaluronic acid modifier |
KR101440170B1 (ko) * | 2007-02-21 | 2014-09-12 | 모찌다 세이야쿠 가부시끼가이샤 | 연골 질환 치료용 조성물 |
-
2008
- 2008-02-21 KR KR1020097016862A patent/KR101440170B1/ko active IP Right Grant
- 2008-02-21 ES ES08720791.6T patent/ES2637163T3/es active Active
- 2008-02-21 AU AU2008217916A patent/AU2008217916B2/en not_active Ceased
- 2008-02-21 BR BRPI0807739-8A patent/BRPI0807739B1/pt not_active IP Right Cessation
- 2008-02-21 NZ NZ578985A patent/NZ578985A/en not_active IP Right Cessation
- 2008-02-21 CA CA2912930A patent/CA2912930C/en not_active Expired - Fee Related
- 2008-02-21 CA CA2677436A patent/CA2677436C/en not_active Expired - Fee Related
- 2008-02-21 WO PCT/JP2008/052999 patent/WO2008102855A1/ja active Search and Examination
- 2008-02-21 NZ NZ596105A patent/NZ596105A/xx not_active IP Right Cessation
- 2008-02-21 JP JP2009500239A patent/JP4740369B2/ja active Active
- 2008-02-21 US US12/311,426 patent/US8372394B2/en active Active
- 2008-02-21 EP EP17157935.2A patent/EP3189859B8/en active Active
- 2008-02-21 EP EP08720791.6A patent/EP2127687B1/en active Active
- 2008-02-21 MX MX2009008760A patent/MX2009008760A/es active IP Right Grant
- 2008-02-21 CN CN200880004925.6A patent/CN101951969B/zh not_active Expired - Fee Related
- 2008-02-21 CN CN201510202005.7A patent/CN104906126B/zh not_active Expired - Fee Related
-
2009
- 2009-08-11 IL IL200342A patent/IL200342A/en active IP Right Grant
-
2011
- 2011-04-28 JP JP2011101107A patent/JP5425134B2/ja active Active
-
2013
- 2013-01-09 US US13/737,171 patent/US9216201B2/en active Active
-
2014
- 2014-01-06 IL IL230335A patent/IL230335A/en active IP Right Grant
Patent Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5589591A (en) | 1986-07-03 | 1996-12-31 | Advanced Magnetics, Inc. | Endotoxin-free polysaccharides |
JPH0513136A (ja) | 1991-06-28 | 1993-01-22 | Nec Corp | Icソケツト |
JPH08269102A (ja) | 1995-03-30 | 1996-10-15 | Shiseido Co Ltd | エンドトキシンフリーのβ1,3−グルカン及びその製造法並びに医療用ゲル素材 |
JPH09324001A (ja) | 1996-04-02 | 1997-12-16 | Kyowa Hakko Kogyo Co Ltd | ヒアルロン酸ナトリウムの精製法 |
JPH10101577A (ja) * | 1996-09-27 | 1998-04-21 | Nikken Chem Co Ltd | 関節可動域低下症の予防・治療薬 |
JP2002530440A (ja) | 1998-11-13 | 2002-09-17 | シーピー ケルコ ユー.エス.インク. | エンドトキシンレベルが低い生体高分子塩、その生体高分子組成物およびこれを製造する方法 |
WO2002055073A1 (fr) * | 2001-01-05 | 2002-07-18 | Kyowa Kakko Kogyo Co., Ltd. | Agents prophylactiques de l'arthrite |
WO2003099339A1 (fr) * | 2002-05-29 | 2003-12-04 | Anges Mg, Inc. | Composition leurre pour traiter et prevenir une affection inflammatoire |
JP2005036036A (ja) | 2003-07-16 | 2005-02-10 | Tanabe Seiyaku Co Ltd | エンドトキシン除去方法 |
WO2006044342A2 (en) | 2004-10-12 | 2006-04-27 | Fmc Biopolymer As | Self-gelling alginate systems and uses thereof |
JP2007041520A (ja) | 2005-07-29 | 2007-02-15 | Optimax Technology Corp | 光学補償膜の製造方法及び光学補償膜を具有する偏光板 |
JP2007075425A (ja) * | 2005-09-15 | 2007-03-29 | Mochida Pharmaceut Co Ltd | アルギン酸を含む創傷被覆材 |
JP2007277005A (ja) | 2006-03-17 | 2007-10-25 | Kyocera Mita Corp | 画像形成装置 |
Non-Patent Citations (22)
Title |
---|
"Tokyo Medical and Dental University", MARUZEN CO., LTD., pages: 235 - 243 |
APPL. MICROBIOL. BIOTECHNOL., vol. 40, 1994, pages 638 - 643 |
CAY M. MIERISCH ET AL.: "Transforming Growth Factor (3 in Calcium Alginate Beads for the Treatment of Articular Cartilage Defects in the Rabbit", THE JOURNAL OF ARTHROSCOPIC AND RELATED SURGERY, vol. 18, no. 8, October 2002 (2002-10-01), pages 892 - 900 |
CHIKAKO YOMOTA ET AL., BULL. NATL. HEALTH SCI., vol. 117, 1999, pages 135 - 139 |
CHIKAKO YOMOTA ET AL., BULL. NATL. HEALTH SCI., vol. 121, 2003, pages 30 - 33 |
CHOJI SHIMIZU ET AL., J. RHEUMATOL., vol. 25, 1998, pages 1813 - 1819 |
DAVID R. DIDUCH ET AL.: "Chondrocyte Transplantation into Articular CartilageDefects with Use of Calcium Alginate: The Fate of the Cells", J BONE JOINT SURG.AM, vol. 85, 2003, pages 1757 - 1767 |
DAVID R. DIDUCH ET AL.: "Marrow Stromal Cells Embedded in Alginate for Repair of Osteochondral Defects", THE JOURNAL OF ARTHROSCOPIC AND RELATED SURGERY, vol. 16, no. 6, September 2000 (2000-09-01), pages 571 - 577 |
E. FRAGONAS ET AL.: "Articular Cartilage Repair in Rabbits by Using Suspensions of Allogenic Chondrocytes in Alginate", BIOMATERIALS, vol. 21, 2000, pages 795 - 801, XP004196854, DOI: doi:10.1016/S0142-9612(99)00241-0 |
FRAGONAS E. ET AL.: "Articular cartilage repair in rabbits by using suspensions of allogenic chondrocytes in alginate", BIOMATERIALS, vol. 21, 2000, pages 795 - 801, XP004196854 * |
GABRIELE, G. ET AL., BIOMATERIAL, vol. 21, 2000, pages 2561 - 2574 |
HOSHIKAWA A. ET AL.: "OA to Bioengineerng", IGAKU NO AYUMI, vol. 211, no. 4, 2004, pages 269 - 273, XP008110925 * |
IGARASHI T. ET AL.: "Nankotsu Saisei ni Muketa Kokasei Kojundo Tei-Endotoxin Alginic Acid Gel o Mochiita Shinki Ishoku System no Kaihatsu", J. JPN. ORTHOP. ASSOC., vol. 81, no. 8, 2007, pages S838, XP008110924 * |
KEITH T. PAIGE ET AL.: "De Novo Cartilage Generation Using Calcium Alginate-Chondrocyte Constructs", PLASTIC AND RECONSTRUCTIVE SURGERY, vol. 97, 1996, pages 168 - 178 |
MATSUMINE A. ET AL.: "3. Hone Nankotsu no Saisei . Shufuku - Rinsho Oyo eno Tenbo", EXPERIMENTAL MEDICINE, vol. 20, 2002, pages 2569 - 2574, XP008110917 * |
SCIENCE, vol. 122, 1952, pages 501 |
See also references of EP2127687A4 |
SHIZUHIKO IHARA ET AL., FOLIA PHARMACOL. JAPON, vol. 100, 1992, pages 359 - 365 |
THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, vol. 199, 1967, pages 519 |
TOSHIYUKI KIKUCHI ET AL.: "to evaluate effects of the administered drugs", OSTEOARTHRITIS AND CARTILAGE, vol. 4, 1996, pages 99 - 110 |
VIGNON, E. ET AL.: "Histological cartilage changes in a rabbit model of osteoarthritis", J. RHEUMATOL., vol. 14, 1987, pages 104 - 6 |
VIROLOGY, vol. 8, 1959, pages 396 |
Cited By (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012512846A (ja) * | 2008-12-19 | 2012-06-07 | セリェリクス、ソシエダッド、アノニマ | 脂肪幹細胞を含んでなる組成物 |
US9821027B2 (en) | 2011-08-23 | 2017-11-21 | Mochida Pharmaceutical Co., Ltd. | Method for regenerating cartilage comprising applying a monovalent metal salt of alginic acid and SDF-1 |
WO2013027854A1 (ja) * | 2011-08-23 | 2013-02-28 | 持田製薬株式会社 | 軟骨再生用組成物 |
JPWO2013027854A1 (ja) * | 2011-08-23 | 2015-03-23 | 持田製薬株式会社 | 軟骨再生用組成物 |
JP2022048356A (ja) * | 2015-09-07 | 2022-03-25 | 持田製薬株式会社 | アルギン酸凍結乾燥製剤 |
JPWO2017043485A1 (ja) * | 2015-09-07 | 2018-08-16 | 持田製薬株式会社 | アルギン酸凍結乾燥製剤 |
JP7367089B2 (ja) | 2015-09-07 | 2023-10-23 | 持田製薬株式会社 | アルギン酸凍結乾燥製剤 |
WO2017043485A1 (ja) | 2015-09-07 | 2017-03-16 | 持田製薬株式会社 | アルギン酸凍結乾燥製剤 |
JP7020913B2 (ja) | 2015-09-07 | 2022-02-16 | 持田製薬株式会社 | アルギン酸凍結乾燥製剤 |
US10966929B2 (en) | 2015-09-07 | 2021-04-06 | Mochida Pharmaceutical Co., Ltd. | Freeze-dried alginic acid preparation |
JP2021154163A (ja) * | 2016-03-23 | 2021-10-07 | 国立大学法人北海道大学 | 椎間板治療用組成物 |
JP7314207B2 (ja) | 2016-03-23 | 2023-07-25 | 国立大学法人北海道大学 | 椎間板治療用組成物 |
JPWO2017163603A1 (ja) * | 2016-03-23 | 2019-01-31 | 国立大学法人北海道大学 | 椎間板治療用組成物 |
JP2019088900A (ja) * | 2016-03-23 | 2019-06-13 | 国立大学法人北海道大学 | 椎間板治療用組成物 |
WO2017163603A1 (ja) | 2016-03-23 | 2017-09-28 | 国立大学法人北海道大学 | 椎間板治療用組成物 |
JP7191007B2 (ja) | 2017-03-02 | 2022-12-16 | 持田製薬株式会社 | 線維軟骨組織損傷治療用組成物 |
JPWO2018159768A1 (ja) * | 2017-03-02 | 2019-12-26 | 持田製薬株式会社 | 線維軟骨組織損傷治療用組成物 |
US11426425B2 (en) | 2017-03-02 | 2022-08-30 | Mochida Pharmaceutical Co., Ltd. | Composition for treating fibrocartilage tissue damage |
WO2018159768A1 (ja) | 2017-03-02 | 2018-09-07 | 持田製薬株式会社 | 線維軟骨組織損傷治療用組成物 |
JPWO2018164128A1 (ja) * | 2017-03-07 | 2020-04-16 | 持田製薬株式会社 | アルギン酸液剤 |
WO2018164128A1 (ja) | 2017-03-07 | 2018-09-13 | 持田製薬株式会社 | アルギン酸液剤 |
EP4295838A2 (en) | 2017-03-07 | 2023-12-27 | Mochida Pharmaceutical Co., Ltd. | Alginate liquid formulation |
US11969437B2 (en) | 2017-03-07 | 2024-04-30 | Mochida Pharmaceutical Co., Ltd. | Alginate liquid preparation |
WO2019182015A1 (ja) | 2018-03-22 | 2019-09-26 | 持田製薬株式会社 | 非ステロイド性抗炎症性化合物結合アルギン酸誘導体 |
WO2021145404A1 (ja) * | 2020-01-17 | 2021-07-22 | 持田製薬株式会社 | 骨髄液を用いた軟骨損傷治療材 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008102855A1 (ja) | 軟骨疾患治療用組成物 | |
EP2628486A3 (en) | Method for treating bone fracture with anti-sclerostin antibodies | |
WO2010151338A3 (en) | Myostatin inhibitor enhancement of musculoskeletal repair | |
MX2010004484A (es) | Composicion para tratamiento de enfermedad de las articulaciones. | |
WO2010071826A3 (en) | Methods for treating osteoclast-related disease, compounds and compositions thereof | |
WO2015009991A8 (en) | Methods, systems, and compositions for promoting bone growth | |
WO2007138466A3 (en) | Pharmaceutical compositions comprising meloxicam and tramadol combination | |
WO2007070547A3 (en) | Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid | |
WO2006093348A3 (en) | Method and composition for treating peripheral vascular diseases | |
WO2007046097A3 (en) | Topical compositions for the treatment of depilation-induced skin irritation or prevention thereof | |
EP2418945A4 (en) | Mineral salt-sulfuric acid compositions and methods for their use | |
WO2010081091A3 (en) | Therapeutic compositions for treatment of corneal disorders | |
WO2009111418A3 (en) | Ketorolac tromethamine compositions for treating or preventing ocular pain | |
WO2007144493A3 (fr) | Utilisation therapeutique simultanee, separee ou etalee dans le temps d'au moins une neurotoxine botulique, et d'au moins un derive opiace | |
EP1924269A4 (en) | VEGETATION WATER-BASED COMPOSITION FOR THE TREATMENT OF INFLAMMATORY CUTANEOUS DISEASES | |
EA201071293A1 (ru) | Композиция для укладки волос | |
WO2007120485A3 (en) | Methods of treating pain with alkylxanthines and antiepileptics and compositions for use therefor | |
WO2007014253A3 (en) | Method of treating or preventing tissue deterioration, injury or damage due to congestive heart failure | |
WO2011044523A3 (en) | Compositions and methods for treating obesity | |
WO2011028737A3 (en) | Bisphosphonate compositions and methods for treating heart failure | |
WO2008073466A3 (en) | Alpha b-crystallin as a therapy for inflammation | |
WO2007081808A3 (en) | Compounds and derivatives for the treatment of medical conditions by modulating hormone-sensitive lipase activity | |
WO2010094734A3 (en) | Methods for identifying and compounds useful for the diagnosis and treatment of diseases involving inflammation | |
HK1131340A1 (en) | Compositions comprising alpha-ketoglutarate and their use for modulating muscle performance | |
WO2006101910A3 (en) | Peptide compounds and methods of using peptide compounds to treat conditions affecting the cardiac, pulmonary, and nervous systems |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200880004925.6 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08720791 Country of ref document: EP Kind code of ref document: A1 |
|
DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2009500239 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12311426 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2677436 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1488/MUMNP/2009 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200342 Country of ref document: IL Ref document number: 578985 Country of ref document: NZ Ref document number: 2008217916 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020097016862 Country of ref document: KR |
|
REEP | Request for entry into the european phase |
Ref document number: 2008720791 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008720791 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/A/2009/008760 Country of ref document: MX |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2008217916 Country of ref document: AU Date of ref document: 20080221 Kind code of ref document: A |
|
DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) | ||
ENP | Entry into the national phase |
Ref document number: PI0807739 Country of ref document: BR Kind code of ref document: A2 Effective date: 20090814 |